DOJ wants monopolists to play nicer
Obama's new antitrust chief Christine Varney promised the administration would be tough on companies that violate anti-monopoly laws. This likely means more suits against big business. Jill Barshay reports.
Live Nation President and CEO Michael Rapino, left, and Ticketmaster Entertainment CEO Irving Azoff, right, testify before the Senate Judiciary Committee's Antitrust, Competition Policy and Consumer Rights Subcommittee (Chip Somodevilla/Getty Images)
More on Mergers/Acquisitions
TEXT OF STORY
Tess Vigeland: Health care isn't the only target of reform for the Obama administration. Today it announced it's getting tough on corporate monopolies. The Justice Department started off the morning by tearing up a Bush administration report about dealing gently with monopolists -- or companies with huge market shares. Then the new antitrust chief started to explain the new policy shift for big business. Jill Barshay reports.
JILL BARSHAY: The Bush administration never filed a single case against a company for violating anti-monopoly laws. Obama's new antitrust chief Christine Varney promised to prevent big businesses from using their power to squelch smaller competitors.
CHRISTINE Varney: It is time for the antitrust division to step up its efforts.
It wasn't clear whom Varney would go after first.
Herb Hovenkamp is an antitrust expert at the University of Iowa College of Law. He said firms like Microsoft and Intel need to watch out. For not sharing information with rivals. Or for giving deep discounts to computer makers who don't buy competitors' chips.
HERB Hovenkamp: That will bring us more closely into alignment with Europe, who takes a much more aggressive position on these things than we do.
But Hovenkamp doesn't think Obama is going to break up monopolies, just make them play nicer with the competition.
Mark Kovner is an antitrust lawyer at Kirkland and Ellis. He expects his practice -- defending big businesses -- to get a lot busier.
MARK Kovner: In an economy that's experiencing some difficulties, people often resort to anti-competitive agreements as their back is against the wall, and their profits are going down, and they need to maintain their market share, and they need to make more money.
Kovner says he expects the pharmaceutical industry to be in the hot seat for the deals they strike to delay the production of cheaper, generic drugs.
I'm Jill Barshay for Marketplace.
Comments
Comment | Refresh
Post a Comment: Please be civil, brief and relevant.
Email addresses are never displayed, but they are required to confirm your comments. All comments are moderated. Marketplace reserves the right to edit any comments on this site and to read them on the air if they are extra-interesting. Please read the Comment Guidelines before posting.
You must be 13 or over to submit information to American Public Media. The information entered into this form will not be used to send unsolicited email and will not be sold to a third party. For more information see Terms and Conditions and Privacy Policy.